Know Cancer

or
forgot password

Pulmonary Interstitial Lymphography in Early Stage Lung Cancer


N/A
18 Years
N/A
Not Enrolling
Both
Lung Cancer, Lung Cancer Non-Small Cell Cancer (NSCLC), Lung Cancer Small Cell Lung Cancer (SCLC), Mesothelioma

Thank you

Trial Information

Pulmonary Interstitial Lymphography in Early Stage Lung Cancer


Inclusion Criteria:

- Either 1. Established primary lung cancer/ cancer metastatic to lung,
OR 2. Lesion suspicious for malignancy in lung, according to the following criteria:

A. Histopathologically confirmed lung cancer or cancer metastatic to lung, OR B. Plan for
biopsy of suspicious lung mass based on imaging (growth on serial CT scan or nodule/mass
with focal hypermetabolism on FDG-PET scan), OR C. Known metastatic cancer, with
metastases to the lung based on imaging

- Age > 18 years old

- Eastern Clinical Oncology Group performance status 0, 1 or 2 (Appendix IV)

- No prior surgery, chemotherapy, or radiation for the current lung tumor

- Both men and women and members of all races and ethnic groups are eligible for this
trial.

Exclusion Criteria:- Prior radiotherapy to thorax

- Allergy to iodine

- Contraindication to receiving radiotherapy, unless undergoing surgery

- Women who are pregnant

Type of Study:

Interventional

Study Design:

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

- Feasibility and safety of identification of primary nodal drainage for purpose of radiation therapy targeting

Outcome Time Frame:

15 months

Safety Issue:

No

Principal Investigator

Dr. Billy W. Loo Jr. M.D. Ph.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Stanford University

Authority:

United States: Institutional Review Board

Study ID:

LUN0040

NCT ID:

NCT01188486

Start Date:

August 2010

Completion Date:

September 2013

Related Keywords:

  • Lung Cancer
  • Lung Cancer Non-Small Cell Cancer (NSCLC)
  • Lung Cancer Small Cell Lung Cancer (SCLC)
  • Mesothelioma
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms
  • Mesothelioma
  • Small Cell Lung Carcinoma

Name

Location

Stanford University School of Medicine Stanford, California  94305-5317